{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:09:18Z","timestamp":1778854158779,"version":"3.51.4"},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.amjms.2026.04.007","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:25:32Z","timestamp":1776813932000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comments on \u2018Effect of therapeutic lifestyle changes on patients with overweight\/obesity and non-alcoholic fatty liver disease: A randomized controlled trial\u2019"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3678-7348","authenticated-orcid":false,"given":"Shuyi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjms.2026.04.007_bib0001","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.amjms.2024.10.005","article-title":"Effect of therapeutic lifestyle changes on patients with overweight\/obesity and non-alcoholic fatty liver disease: a randomized controlled trial","volume":"369","author":"Huang","year":"2025","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.amjms.2026.04.007_bib0002","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab Rev"},{"issue":"1","key":"10.1016\/j.amjms.2026.04.007_bib0003","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.amjms.2026.04.007_bib0004","article-title":"CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials","volume":"389","author":"Hopewell","year":"2025","journal-title":"BMJ"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962926001515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962926001515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:25:18Z","timestamp":1778851518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962926001515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":4,"alternative-id":["S0002962926001515"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2026.04.007","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comments on \u2018Effect of therapeutic lifestyle changes on patients with overweight\/obesity and non-alcoholic fatty liver disease: A randomized controlled trial\u2019","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2026.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}